Download PDF
1 / Pages

Other users also viewed these articles

Colombian experience with the use of tofacitinib in severe acute ulcerative colitis: A case series study Viviana Parra-Izquierdo; Juan Sebastián Frías-Ordoñez; Fabián Juliao-Baños; Carlos Cuadros; Consuelo Romero Sanchez; Cristian Flórez-Sarmiento;
Gastroenterol Hepatol. 2024;47:582-90
Tofacitinib in the treatment of moderate to severe ulcerative colitis in Colombian pediatric patients: Real world experience Viviana Parra-Izquierdo; Juan Sebastián Frías-Ordoñez; Carlos Cuadros; Melquicedec Vargas; José Fernando Vera Chamorro; Consuelo Romero Sanchez; Cristian Flórez-Sarmiento;
Gastroenterol Hepatol. 2024;47:574-81
Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies Xavier Calvet; Daniel Carpio; Iago Rodríguez-Lago; Rosario García-Vicuña; Manuel Barreiro-de-Acosta; Xavier Juanola; Mariam Aguas; Concepción Castillo; Jordi Gratacós;
Gastroenterol Hepatol. 2021;44:587-98